logo
Select company
Select metric
$ -0.61EBIT per Share
VS
Market
26
Sector
60
Industry
53
History
18
$ 0.53Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -25.31M$ -0.61141.54M
3/31/2025$ -30M$ -0.85135.23M
12/31/2024$ -42.82M$ -2.09120.46M
9/30/2024$ -35.22M$ -1.85119.08M
6/30/2024$ -33.79M$ -1.79118.89M
3/31/2024$ -30.62M$ -1.7118.05M
12/31/2023$ -21.52M$ -1.25117.21M
9/30/2023$ -15.41M$ -0.9117.18M
6/30/2023$ -6.93M$ -0.41116.84M
3/31/2023$ 8.31M$ 0.5116.75M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) EBITPS stands at $ -0.14.
  • Over the past 5 years, PROPHASE LABS INC's average EBITPS has been $ -0.19.
  • The median EBITPS for PROPHASE LABS INC during this period was $ -0.21
  • PROPHASE LABS INC reached its highest EBITPS over the past 5 years at $ 2.43.
  • The lowest EBITPS recorded by PROPHASE LABS INC in the same timeframe $ -2.09

PROPHASE LABS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
BNBX : APPLIED DNA SCIENCES INC $ -23.05INBS : INTELLIGENT BIO SOLUTIONS INC $ -1.99TNON : TENON MEDICAL INC $ -1.67TRAW : TRAWS PHARMA INC $ 15.1TXMD : THERAPEUTICSMD INC $ -0.05LGVN : LONGEVERON INC $ -1.23BOLT : BOLT BIOTHERAPEUTICS INC $ -26.45LPCN : LIPOCINE INC $ -0.84CYCN : CYCLERION THERAPEUTICS INC $ -0.63XAIR : BEYOND AIR INC $ -7.88

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for PROPHASE LABS INC is calculated as follows: EBIT [ $ -1.61M ] / (Shares WA [ 11.6M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -0.14 ]

PRPH - EBIT per Share, Last 5 years

$ -2.09

Minimum

Dec 31, 2024

$ 2.43

Maximum

Sep 30, 2022

$ -0.19

Average

$ -0.21

Median

EBITPS Benchmark Analysis

The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.43.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.72
max$ 10.81
average$ 1.16
median$ 0.39
std$ 3.43